Mapletree Greater China trust buys Sandhill Plaza in Shanghai for S$402m
MAPLETREE Greater China Commercial Trust (MGCCT) has acquired Sandhill Plaza in Shanghai for about S$402 million from MSREF VII Leaphart BV.
This translates into a purchase consideration of 1,888.1 million renminbi (or approximately S$412.2 million), which comprises the property purchase price of 1,840.3 million renminbi (or approximately S$401.8 million) for Sandhill Plaza and the estimated working capital adjustments.
Said Cindy Chow, chief executive officer of MGCCT Management: "We are pleased to announce our first acquisition since listing, with the purchase of Sandhill Plaza - a premium quality business park located in Zhangjiang Hi-tech Park in Shanghai. With its good location, quality building specifications, high occupancy rate, strong tenancy profile, and attractive rental growth opportunity within a strong rental market, the acquisition of Sandhill Plaza is in line with MGCCT's strategy to invest in best-in-class real estate assets for commercial purposes in the Greater China region. This marks the start of growing MGCCT through accretive acquisitions in addition to organic growth and asset enhancement initiatives."
Under the terms of the agreement, MGCCT will acquire 100 per cent interest in Glamour II Limited (an entity incorporated in the Cayman Islands), which holds 100 per cent interest in China Orient Limited (an entity incorporated in Hong Kong), which in turns holds 100 per cent interest in Shanghai Zhan Xiang Real Estate Company Limited (an entity incorporated in the People's Republic of China), the registered owner of Sandhill Plaza.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Google parent announces first-ever dividend; beats on sales, profit; shares soar
Baltimore’s trapped ships start leaving as new channel opens
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336